HRT Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

HRT Financial’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-11,771	Closed	-$745K	–	165
2016 Q2	$745K	Sell	11,771 -11,515	-49%	-$724K	0.45%	37
2016 Q1	$1.4M	Buy	+23,286	New	+$1.42M	1.46%	15
2015 Q4	–	Sell	-29,958	Closed	-$1.99M	–	102
2015 Q3	$1.99M	Buy	+29,958	New	+$2.33M	1.7%	12

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

HRT Financial's PJP Position: Q3 2016 in Review

HRT Financial sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2016, closing a stake of 11,771 shares — an estimated $745K sold.

HRT Financial first reported a position in PJP in Q3 2015 and held it in 3 quarters. The position peaked at $1.99M in Q3 2015. 96 funds tracked by Wall St. Rank hold PJP as of Q3 2016.

HRT Financial reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2016 after selling out during the quarter.
HRT Financial sold 11,771 Invesco Pharmaceuticals ETF shares in Q3 2016, an estimated $745K.
HRT Financial first reported a position in Invesco Pharmaceuticals ETF in Q3 2015 and held it in 3 quarters.
HRT Financial's Invesco Pharmaceuticals ETF position peaked at $1.99M in Q3 2015.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2016.

Based on HRT Financial's 13F filing for Q3 2016, filed 9 Nov 2016.